The gynaecological management of women on tamoxifen: a national questionnaire survey

Reference

• Altaras M., Aviram R., Cohen C., Markov S., Goldbern G. and Beyth Y. (1993) Microhysteroscopy and endometrial biopsy results following failed dilation and curettage in women with postmenopausal bleeding. International Journal of Gynaecology and Obstetrics, 42, 255–260.
   PubMed Web of Science ®Google Scholar
• Barakat R.R., Wong G., Curtin J.P., Vlamis V. and Hoskins W.J. (1994) Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecologic Oncology, 55, 164–168.
   PubMed Web of Science ®Google Scholar
• Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J. and van Leeuwen F.E. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial Cancer Risk following Tamoxifen. Lancet, 356, 881–887.
   PubMed Web of Science ®Google Scholar
• Clark T.J., Mann C.H., Shah N., Khan KS., Song F. and Gupta J.K. (2002) Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. British Journal of Obstetrics and Gynae-cology, 109, 313 — 321.
   Google Scholar
• Cohen C., Azaria R., Aviram R., Bernheim J., Tepper R., Cordoba M. and Beyth Y. (1999) Postmenopausal endome-trial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings. Gynecolo-gic and Obstetric Investigation, 48 187— 192.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. (1998) tamox-ifen for early breast cancer: an overview of the randomised trials. Lancet, 352, 1451–1467.
   Google Scholar
• Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., Couture J., Dimitrov N.V., Wolmark N., Wickerham D.L. and Fisher E.R. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. New England Journal of Medicine, 320, 479 — 484.
   Google Scholar
• Fisher B., Costantino J.P., Redmond C.K., Fisher ER., Wickerham D.L. and Cronin W.M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Journal of the National Cancer Institute, 86, 527 — 537.
   Google Scholar
• Fornander T., Rutqvist L.E., Cedermark B., Glas U., Mattsson A., Silfversward C., Skoog L., Somell A., Theve T. and Wilking U. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet, 1, 117–120.
   PubMed Web of Science ®Google Scholar
• Gimpelson R. and Rappold H. (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilation and curettage. American Journal of Obstetrics and Gynecology, 158, 489–492.
   PubMed Web of Science ®Google Scholar
• Hoffken K. (2001) The European experience. Journal of Clinical Oncology, 19, 112S–117S.
   Google Scholar
• Ismail S.M. (1994) Pathology of endometrium treated with tamoxifen. Journal of Clinical Pathology, 47, 827— 833.
   Google Scholar
• Kedar R.P., Bourne T.H., Powles T.J., Collins W.P., Ashley SE., Cosgrove D.O. and Campbell S. (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 343, 1318–1321.
   PubMed Web of Science ®Google Scholar
• Killackey MA., Hakes T.B. and Pierce V.K. (1985) Endome-trial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treatment Reports, 69, 237–238.
   PubMedGoogle Scholar
• Lahti E., Blanco G., Kauppila A., Apaja-Sarkkinen M., Taskinen P.J. and Laatikainen T. (1993) Endometrial change sin postmenopausal breast cancer patients receiving tamox-ifen. Obstetrics and Gynecology, 81, 660–664.
   PubMed Web of Science ®Google Scholar
• Loffer F.D. (1989) Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleed-ing: the value of a negative hysteroscopic view. Obstetrics and Gynecology, 73, 16–20.
   PubMed Web of Science ®Google Scholar
• Love C.D., Muir B.B., Scrimgeour J.B., Leonard R.C., Dillon P. and Dixon J.M. (1999) Investigation of endometrial abnormalities in asymptomatic women treated with tamox-ifen and an evaluation of the role of endometrial screening. Journal of Clinical Oncology, 17, 2050–2054.
   Google Scholar
• Neven P., De Muylder X., Van Belle Y., Vanderick G. and De Muylder E. (1989) Tamoxifen and the uterus and the endometrium. Lancet, 375, 376.
   Google Scholar
• Neven P., De Muylder X. and Ven Belle Y. (1997) Tamoxifen-induced endometrial polyp. New England Journal of Medi-cine, 336, 1389.
   PubMed Web of Science ®Google Scholar
• O'Brien P.M.S. and MacLean A.B. (1999) Hormones and Cancer. London, RCOG Press.
   Google Scholar
• Powles T.J., Hardy J.R., Ashley SE., Farrington G.M., Cosgrove D., Davey J.B., Dowsett M., McKinna J.A., Nash A.G. and Sinnett H.D. (1989) A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60, 126–131.
   PubMed Web of Science ®Google Scholar
• Powles T.J., Tillyer CR., Jones AL., Ashley SE., Treleaven J., Davey J.B. and McKinna J.A. (1990) Prevention of breast cancer with tamoxifen—an update on the Royal Marsden Hospital pilot programme. European Journal of Cancer, 26, 680— 684.
   Google Scholar
• Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J. and Scanlan T.S. (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science, 277, 1508–1510.
   PubMed Web of Science ®Google Scholar
• Iberia G. and Swindell R. (1988) The Christie Hospital adjuvant tamoxifen trial—status at 10 years. British Journal of Cancer, 57, 601 —603.
   Google Scholar
• Iberia G. and Swindell R. (1992) The Christie Hospital adjuvant tamoxifen trial. Journal of the National Cancer Institute Monographs, 11, 121–125.
   Google Scholar
• Stovall T.G., Photopulos G.J., Poston W.M., Ling F.W. and Sandles L.G. (1991) Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstetrics and Gynecol-ogy, 77, 954–956.
   PubMed Web of Science ®Google Scholar
• Sunderland M.C. and Osborne C.K. (1991) Tamoxifen in premenopausal patients with metastatic breast cancer: a review. Journal of Clinical Oncology, 9, 1283— 1297.
   Google Scholar
• Towbin N.A., Gviazda I.M. and March C.M. (1996) Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Amer-ican Journal of Obstetrics and Gynecology, 174, 1678–1682.
   PubMed Web of Science ®Google Scholar